KIF14 and lung adenocarcinoma: In conclusion, the down-regulation of KIF14 occurred in 30% of lung adenocarcinomas, and the expression of KIF14 was negatively correlated with clinical outcomes in the lung adenocarcinoma patients examined in this study.